2023-12-06 08:32:51 ET
- MicroAlgo ( MLGO ) +57% announced plans to establish a practice base to train graduate students for the university
- Pharvaris ( PHVS ) +38% surges on mid-stage success for hereditary angioedema therapy.
- ZyVersa Therapeutics ( ZVSA ) +38% .
- Clean Earth Acquisitions ( CLIN ) +30% .
- Minerva Surgical ( UTRS ) +19% .
- Kamada ( KMDA ) +17% extends commercial deal for U.S. distribution; sees $180M rev over first four years.
- SentinelOne ( S ) +17% Q3 earnings call release
- Phio Pharmaceuticals ( PHIO ) +17% .
- Dune Acquisition Corporation ( DUNE ) +13% .
- Brilliant Acquisition ( BRLI ) +12% .
- Soluna Holdings ( SLNH ) +12% .
- 10X Capital Venture Acquisition ( VCXA ) +12% Announces Shareholder Approval of Business Combination with African Agriculture, Inc.
- Coya Therapeutics ( COYA ) +9% licenses Coya ALS candidate in exclusive deal.
- Mountain Crest Acquisition ( MCAF ) +9% .
- Bit Origin ( BTOG ) +9% .
- Century Therapeutics ( IPSC ) +8% Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus.
- TG Therapeutics ( TGTX ) +8% .
- Altimmune ( ALT ) +7% .
- GSE Systems ( GVP ) +7% .
- Bionomics ( BNOX ) +7% Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting.
- Generation ( GBIO ) +7% .
- iBio ( IBIO ) +7% .
- Syros Pharmaceuticals ( SYRS ) +3% Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine.
- Chanson International Holding ( CHSN ) +6% .
- EyePoint Pharmaceuticals ( EYPT ) +6% prices upsized $200 million stock offering.
For further details see:
TGTX, IBIO and ALT are among pre market gainers